Retraction: a systematic review and meta-analysis of indirect comparison between miRNA and ctDNA in diagnosis of epithelial ovarian cancer
Retraction

Retraction: a systematic review and meta-analysis of indirect comparison between miRNA and ctDNA in diagnosis of epithelial ovarian cancer

Xiaohang Fu1, Yani Liu2

1Department of Postpartum Rehabilitation, The Second Affiliated Hospital of Shaanxi University of Traditional Chinese Medicine, Xi’an, China; 2Department of Gynecology, The Second Affiliated Hospital of Shaanxi University of Traditional Chinese Medicine, Xi’an, China

Correspondence to: Yani Liu. Department of Gynecology, The Second Affiliated Hospital of Shaanxi University of Traditional Chinese Medicine, Xi’an 712000, China. Email: liang3339973@sina.com.

Submitted Feb 28, 2022. Accepted for publication Mar 12, 2022.

doi: 10.21037/tcr-22-862


Retraction to: Transl Cancer Res 2021;10:5372-82

The article “A systematic review and meta-analysis of indirect comparison between miRNA and ctDNA in diagnosis of epithelial ovarian cancer” (doi: 10.21037/tcr-21-2609) published in the Vol 10, No 12 (December 2021) issue of Translational Cancer Research has been retracted at the request by all the authors because of controversial data in the study. We apologize for the inconvenience caused.


Footnote

Conflicts of Interest: Both authors have completed the ICMJE uniform disclosure form (available at https://tcr.amegroups.com/article/view/10.21037/tcr-22-862/coif). The authors have no conflicts of interest to declare.

Ethical Statement: The authors are accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.


Cite this article as: Fu X, Liu Y. Retraction: a systematic review and meta-analysis of indirect comparison between miRNA and ctDNA in diagnosis of epithelial ovarian cancer. Transl Cancer Res 2022;11(4):980. doi: 10.21037/tcr-22-862